| Overview |
| bsm-90070R |
| CD13 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human CD13 |
| 400-464/967 |
| Monoclonal |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 290 |
| P15144 |
| ANPEP; Alanyl Aminopeptidase Membrane; AP-N; HAPN; Microsomal Aminopeptidase; Aminopeptidase N; Aminopeptidase M; LAP1; P150; CD13; PEPN; Myeloid Plasma Membrane Glycoprotein CD13; Alanyl (Membrane) Aminopeptidase; Membrane Alanyl Aminopeptidase; EC 3.4.11.2; Gp150; GP150; AP-M; APN; Alanyl; Aminopeptidase; CD13 Antigen; EC 3.4.11 |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz